Analyst Ratings for Pfizer (PFE) [Neutrals]
PFE Rating Summary
PFE Price Target Summary
- Highest: $33.00 (Jefferies)
- Lowest: $22.00 (Barclays)
- Average: $28.25
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.25 (-2.5%)
Avg. $ Target:
$28.25 (-2.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/7/2013 | Credit Suisse | New Coverage | Neutral (N/A) |
29.00 (N/A) |
27.32 | 28.97 | 6.04% | Details |
| 11/27/2012 | MKM Partners » Updated 1/30/2013 |
Downgrade | Neutral (Buy) |
28.00 (25.00) |
24.49 | 28.97 | 18.29% | Details |
| 11/14/2011 | Leerink Swann » Updated 4/10/2013 |
Downgrade | Market Perform (N/A) |
N/A (N/A) |
19.99 | 28.97 | 44.92% | Details |
| 11/1/2011 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
19.67 | 28.97 | 47.28% | Details |
| 9/14/2011 | Barclays » Updated 8/1/2012 |
Downgrade | Equalweight (N/A) |
22.00 (N/A) |
18.33 | 28.97 | 58.05% | Details |
| 5/21/2010 | Jefferies » Updated 4/10/2013 |
New Coverage | Hold (N/A) |
33.00 (31.00) |
15.06 | 28.97 | 92.36% | Details |
| 4/8/2010 | Hapoalim Securities | New Coverage | Hold (N/A) |
N/A (N/A) |
16.71 | 28.97 | 73.37% | Details |
